LCB3   Click here for help

GtoPdb Ligand ID: 11237

Comment: A synthetic peptide that binds potently to the ACE2 binding domain of the SARS-CoV-2 spike protein, and blocks entry of SARS-CoV-2 in vitro [1]. The chemical SMILES was generated using the HELM editor. The crystal structure of LCB3 in complex with SARS-CoV-2 spike protein has been deposited with the PDB, ID 7JZN
Click here for help
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)O)CC(C)C)CC(C)C)CCC(=O)O)CCCCN)CC(C)C)CCC(=O)O)CCC(=O)O)C(C)C)C(C)C)CCCCN)CCC(=O)O)CC(C)C)CCCCN)CCC(=O)N)CCCNC(=N)N)CC(=O)O)CC(=O)N)CC(=O)N)CCCCN)Cc1ccc(cc1)O)C)CCCCN)CC(=O)O)C)CC(C)C)CCC(=O)O)Cc1ccccc1)CC(C)C)CCC(=O)N)Cc1ccccc1)C(C)C)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N)N)CC(=O)O)CC(=O)O)CCC(=O)O)CC(C)C)Cc1nc[nH]c1)CCSC)CC(C)C)CCSC)CC(=O)O)CC(C)C)Cc1ccc(cc1)O)CCC(=O)O)C)CC(C)C)Cc1nc[nH]c1)Cc1ccccc1)C)CCCCN)CC(=O)O)CCC(=O)O)CCC(=O)O)CCCCN
Isomeric SMILES NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)O)CC(C)C)CC(C)C)CCC(=O)O)CCCCN)CC(C)C)CCC(=O)O)CCC(=O)O)C(C)C)C(C)C)CCCCN)CCC(=O)O)CC(C)C)CCCCN)CCC(=O)N)CCCNC(=N)N)CC(=O)O)CC(=O)N)CC(=O)N)CCCCN)Cc1ccc(cc1)O)C)CCCCN)CC(=O)O)C)CC(C)C)CCC(=O)O)Cc1ccccc1)CC(C)C)CCC(=O)N)Cc1ccccc1)C(C)C)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N)N)CC(=O)O)CC(=O)O)CCC(=O)O)CC(C)C)Cc1nc[nH]c1)CCSC)CC(C)C)CCSC)CC(=O)O)CC(C)C)Cc1ccc(cc1)O)CCC(=O)O)C)CC(C)C)Cc1nc[nH]c1)Cc1ccccc1)C)CCCCN)CC(=O)O)CCC(=O)O)CCC(=O)O)CCCCN
InChI Key AYKCULXVFGARTK-NUIKKLCPSA-N
Bioactivity Comments
LCB3 neutralises SARS-CoV-2 infection of Vero E6 cells with an IC50 of 48.1 pM. It also binds to SARS-CoV spike protein.
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CoV Spike glycoprotein SARS-CoV-2 None Binding >9.0 pKd - 1
pKd >9.0 (Kd <1x10-9 M) [1]